Transformed strain derived from strain deficient in multidrug efflux protein, and bioconversion method using the same

Details for Australian Patent Application No. 2008219996 (hide)

Owner Mercian Corporation

Inventors Kabumoto, Hiroki; Ito, Shoji; Ochiai, Atsushi; Fujii, Tadashi; Machida, Kazuhiro; Fujii, Yoshikazu

Agent Pizzeys

Pub. Number AU-A-2008219996

PCT Pub. Number WO2008/105513

Priority 2007-050935 01.03.07 JP

Filing date 28 February 2008

Wipo publication date 4 September 2008

International Classifications

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12P 7/02 (2006.01) Preparation of oxygen-containing organic compounds - containing a hydroxy group

C12P 33/06 (2006.01) Preparation of steroids

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

24 September 2009 PCT application entered the National Phase

  PCT publication WO2008/105513 Priority application(s): WO2008/105513

1 October 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Transformed strains originated from multidrug efflux protein defective strains and a method for microbial conversion using them

25 February 2010 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Ito, Shoji to Ito, Masashi

2 February 2012 Assignment before Grant

  Mercian Corporation The application has been assigned to MicroBiopharm Japan Co., Ltd

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008220009-Macrocyclic compound

2008219991-Method for improvement of efficiency of transformation in plant, comprising coculture step for culturing plant tissue in co-culture medium containing 3,6-dichloro-o-anisic acid